KICK-IN CERTIFICATE LINKED TO WORST OF WITH EARLY REDEMPTION FEATURE - BAYER/GSK PLC/PFIZER INC Stock

Certificat

W4HSP7

DE000UL4HSP7

Market Closed - Borsa Italiana 11:44:59 2024-05-31 am EDT
520.8 EUR +1.45% Intraday chart for KICK-IN CERTIFICATE LINKED TO WORST OF WITH EARLY REDEMPTION FEATURE - BAYER/GSK PLC/PFIZER INC
1 month+11.69%
3 months+5.47%
Date Price Change
24-05-31 520.8 +1.45%
24-05-30 513.3 +5.93%
24-05-29 484.6 -4.61%
24-05-28 508 -2.74%
24-05-27 522.2 +2.43%

Real-time Borsa Italiana

Last update May 31, 2024 at 11:44 am EDT

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying PFIZER, INC.
Issuer UBS
W4HSP7
ISINDE000UL4HSP7
Date issued 2023-04-27
Maturity 2028-04-27 (1426 Days)
Parity 1 : 1
Emission price 1,000
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1,001
Lowest since issue 427.6
Spread 10
Spread %1.90%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66 USD
Average target price
31.92 USD
Spread / Average Target
+11.36%
Consensus
  1. Stock Market
  2. Certificates
  3. W4HSP7 Certificat